Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Moodys
Johnson and Johnson
AstraZeneca
McKinsey

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Betaxolol hydrochloride - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for betaxolol hydrochloride and what is the scope of patent protection?

Betaxolol hydrochloride is the generic ingredient in six branded drugs marketed by Akorn, Apotex Inc, Medimetriks Pharms, Wockhardt, Sandoz Inc, Novartis, Epic Pharma, Kvk Tech, Sanofi Aventis Us, and Alcon, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for betaxolol hydrochloride. Seven suppliers are listed for this compound.

Recent Clinical Trials for betaxolol hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Health Science Center, HoustonPhase 1
Smith-Kettlewell Eye Research InstitutePhase 1
University of Minnesota - Clinical and Translational Science InstitutePhase 1

See all betaxolol hydrochloride clinical trials

Pharmacology for betaxolol hydrochloride
Medical Subject Heading (MeSH) Categories for betaxolol hydrochloride
Synonyms for betaxolol hydrochloride
(+-)-1-(p-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol hydrochloride
1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylaminopropan-2-ol hydrochloride
1-(Isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol hydrochloride
1-(isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-2-propanol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride
1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanol hydrochloride
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanolhydrochloride
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)-
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-,hydrochloride
63659-18-7 (Parent)
63659-19-8
659X198
72424-72-7
A803574
AB2000314
AC-1412
AC1L331T
AC1Q3DQ4
AKOS015843993
alo 1401-02
AN-14973
API0001701
AS-18082
B 5683
B4474
BC227944
BCP02967
BCP0726000249
BCP9000394
Betaxolo Hydrochloride
Betaxolol (hydrochloride)
Betaxolol for peak identification, European Pharmacopoeia (EP) Reference Standard
Betaxolol HCL
Betaxolol hydrochloride (Betoptic)
Betaxolol hydrochloride (JP17/USP)
Betaxolol hydrochloride [USAN:USP:JAN]
Betaxolol hydrochloride [USAN]
Betaxolol hydrochloride, >98% (HPLC)
Betaxolol hydrochloride, European Pharmacopoeia (EP) Reference Standard
Betaxolol hydrochloride, United States Pharmacopeia (USP) Reference Standard
Betaxolol(hydrochloride)
Betoptic
Betoptic (TN)
Betoptic S
Betoptima
BG0105
CCG-101057
CCG-213473
CHDPSNLJFOQTRK-UHFFFAOYSA-N
CHEBI:643228
CHEMBL1691
CPD000058420
CS-2453
CTK8F0839
D00598
EINECS 264-384-3
EU-0100193
FT-0645228
HMS1569M05
HY-B0381A
I06-1154
Kerlon
Kerlone
Kerlone (TN)
Kerlong
KS-00001F73
Lokren
Lokren ,Kerlone ;Betoptic
LP00193
LS-122006
MCI-144
MFCD00242959
MLS000028464
MLS000758269
MLS000863279
MLS001148209
MLS001424199
MLS002222261
MolPort-003-666-823
NC00307
NCGC00093669-01
NCGC00093669-02
NCGC00260878-01
NSC-760048
NSC760048
Opera_ID_878
Pharmakon1600-01505512
Prestwick_779
Q-200714
S1827
SAM001247084
SCHEMBL42794
SL 75 212-10
SL 75.212-10
SL-75212
SL-75212-10
SMR000058420
SR-01000000108
SR-01000000108-2
SR-01000000108-4
SR-01000000108-9
SW196917-4
TC-071428
Tox21_500193
W0012
Paragraph IV (Patent) Challenges for BETAXOLOL HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
BETOPTIC SOLUTION/DROPS;OPHTHALMIC betaxolol hydrochloride 019270

US Patents and Regulatory Information for betaxolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn BETAXOLOL HYDROCHLORIDE betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075386-001 Jun 30, 2000 AT RX No No   Start Trial   Start Trial   Start Trial
Kvk Tech BETAXOLOL HYDROCHLORIDE betaxolol hydrochloride TABLET;ORAL 078962-002 Jun 27, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-001 Oct 30, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Alcon BETOPTIC PILO betaxolol hydrochloride; pilocarpine hydrochloride SUSPENSION/DROPS;OPHTHALMIC 020619-001 Apr 17, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Epic Pharma BETAXOLOL HYDROCHLORIDE betaxolol hydrochloride TABLET;ORAL 075541-001 Oct 22, 1999 AB RX No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us KERLONE betaxolol hydrochloride TABLET;ORAL 019507-002 Oct 27, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for betaxolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sandoz Inc BETOPTIC betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019270-001 Aug 30, 1985   Start Trial   Start Trial
Novartis BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989   Start Trial   Start Trial
Novartis BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989   Start Trial   Start Trial
Sandoz Inc BETOPTIC betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019270-001 Aug 30, 1985   Start Trial   Start Trial
Sandoz Inc BETOPTIC betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019270-001 Aug 30, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Express Scripts
Colorcon
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.